| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Supplementary Table 14. Gene-set enrichment result by FUMA for T1 Based on GWAS summary statistics, FUMA mapped genes based on the position of Lead SNP, Independent Significant SNP. With all the unique genes associated with 128 ENDOs, gene-set enrichment analysis was performed in FUMA. | |||||||||||||||||||||||||
2 | Category | GeneSet | N_genes | N_overlap | p | adjP | genes | link | ||||||||||||||||||
3 | GWAScatalog | Brain morphology (MOSTest) | 1049 | 144 | 5.74E-145 | 2.54E-141 | FOXE3:FOXD2:INTS3:SLC27A3:GATAD2B:DENND4B:CRTC2:SLC39A1:CREB3L4:JTB:RAB13:RPS27:NUP210L:TPM3:C1orf43:UBAP2L:KCNN3:DCST2:DCST1:EFNA4:EFNA3:EFNA1:SLC50A1:DPM3:KRTCAP2:TRIM46:MUC1:THBS3:MTX1:HCN3:PKLR:RUSC1:ASH1L:MSTO1:YY1AP1:DAP3:GON4L:RXFP4:ARHGEF2:LMNA:RDH14:NT5C1B-RDH14:NT5C1B:CALCRL:TFPI:RPL37A:MAGI1:FOXP1:EPHA3:GMNC:BANK1:SLC39A8:HHIP:ANAPC10:ABCE1:OTUD4:ACSL6:IL3:CSF2:PDLIM4:SLC22A4:SLC22A5:ZKSCAN3:ZSCAN12:ZSCAN23:GPX6:SCAND3:TRIM27:ZNF311:OR2W1:OR2B3:OR2J3:OR2J2:OR14J1:OR5V1:OR12D3:OR12D2:OR11A1:OR10C1:OR2H1:MAS1L:UBD:GABBR1:OR2H2:KIF6:RUNX2:CENPW:AMZ1:GNA12:BBS9:CPED1:PRKAG2:CLDN23:MFHAS1:MSRA:ANGPT1:ENPP2:LPAR1:PAPPA:SKIDA1:MLLT10:DNAJC1:ACTR1A:SUFU:TRIM8:ARL3:FAM53B:ADAMTS8:CCDC91:MSRB3:NUAK1:BMP4:DAAM1:PYGO1:PRTG:WWP2:CLEC18A:C16orf95:CHMP1A:SPATA33:CDK10:SPATA2L:ZNF276:FANCA:SPIRE2:TCF25:MC1R:TUBB3:TUBB3:DEF8:DBNDD1:GAS8:ANKRD13B:CORO6:SSH2:EFCAB5:NSRP1:SLC6A4:MAPT:STH:ARL17B:LRRC37A:LRRC37A2:ARL17A:WNT3:FAM83C:UQCC1:GDF5 | |||||||||||||||||||
4 | GWAScatalog | Subcortical volume (MOSTest) | 522 | 91 | 2.85E-92 | 6.31E-89 | FOXE3:FOXD2:INTS3:SLC27A3:GATAD2B:DENND4B:CRTC2:SLC39A1:CREB3L4:JTB:RAB13:RPS27:NUP210L:TPM3:C1orf43:UBAP2L:KCNN3:DCST2:DCST1:EFNA4:EFNA3:EFNA1:SLC50A1:DPM3:KRTCAP2:TRIM46:MUC1:THBS3:MTX1:HCN3:PKLR:RUSC1:ASH1L:MSTO1:YY1AP1:DAP3:GON4L:RXFP4:ARHGEF2:LMNA:RDH14:NT5C1B-RDH14:NT5C1B:CALCRL:TFPI:RPL37A:MAGI1:FOXP1:EPHA3:GMNC:BANK1:SLC39A8:HHIP:ANAPC10:ABCE1:OTUD4:ACSL6:IL3:CSF2:PDLIM4:SLC22A4:SLC22A5:ZKSCAN3:ZSCAN12:ZSCAN23:GPX6:SCAND3:TRIM27:ZNF311:OR2W1:OR2B3:OR2J3:OR2J2:OR14J1:OR5V1:OR12D3:OR12D2:OR11A1:OR10C1:OR2H1:MAS1L:UBD:GABBR1:OR2H2:KIF6:RUNX2:CENPW:AMZ1:GNA12:BBS9:CPED1:PRKAG2 | |||||||||||||||||||
5 | GWAScatalog | Cortical surface area (MOSTest) | 401 | 61 | 7.59E-56 | 1.12E-52 | FOXE3:FOXD2:INTS3:SLC27A3:GATAD2B:DENND4B:CRTC2:SLC39A1:CREB3L4:JTB:RAB13:RPS27:NUP210L:TPM3:C1orf43:UBAP2L:KCNN3:DCST2:DCST1:EFNA4:EFNA3:EFNA1:SLC50A1:DPM3:KRTCAP2:TRIM46:MUC1:THBS3:MTX1:HCN3:PKLR:RUSC1:ASH1L:MSTO1:YY1AP1:DAP3:GON4L:RXFP4:ARHGEF2:LMNA:RDH14:NT5C1B-RDH14:NT5C1B:CALCRL:TFPI:RPL37A:MAGI1:FOXP1:EPHA3:GMNC:BANK1:SLC39A8:HHIP:ANAPC10:ABCE1:OTUD4:ACSL6:IL3:CSF2:PDLIM4:SLC22A4:SLC22A5 | |||||||||||||||||||
6 | GWAScatalog | Cortical thickness (min-P) | 104 | 40 | 4.20E-54 | 4.64E-51 | FOXE3:FOXD2:INTS3:SLC27A3:GATAD2B:DENND4B:CRTC2:SLC39A1:CREB3L4:JTB:RAB13:RPS27:NUP210L:TPM3:C1orf43:UBAP2L:KCNN3:DCST2:DCST1:EFNA4:EFNA3:EFNA1:SLC50A1:DPM3:KRTCAP2:TRIM46:MUC1:THBS3:MTX1:HCN3:PKLR:RUSC1:ASH1L:MSTO1:YY1AP1:DAP3:GON4L:RXFP4:ARHGEF2:LMNA | |||||||||||||||||||
7 | GWAScatalog | Fish- and plant-related diet | 180 | 46 | 9.24E-53 | 8.18E-50 | SLC27A3:GATAD2B:DENND4B:CRTC2:SLC39A1:CREB3L4:JTB:RAB13:RPS27:NUP210L:TPM3:C1orf43:UBAP2L:ZKSCAN3:ZSCAN12:ZSCAN23:GPX6:SCAND3:TRIM27:ZNF311:OR2W1:OR2B3:OR2J3:OR2J2:OR14J1:OR5V1:OR12D3:OR12D2:OR11A1:OR10C1:OR2H1:MAS1L:UBD:GABBR1:OR2H2:CLDN23:MFHAS1:MSRA:SKIDA1:MLLT10:DNAJC1:EDEM2:MMP24:EIF6:FAM83C:UQCC1 | |||||||||||||||||||
8 | GWAScatalog | Cortical thickness (MOSTest) | 211 | 45 | 1.09E-47 | 8.07E-45 | FOXE3:FOXD2:INTS3:SLC27A3:GATAD2B:DENND4B:CRTC2:SLC39A1:CREB3L4:JTB:RAB13:RPS27:NUP210L:TPM3:C1orf43:UBAP2L:KCNN3:DCST2:DCST1:EFNA4:EFNA3:EFNA1:SLC50A1:DPM3:KRTCAP2:TRIM46:MUC1:THBS3:MTX1:HCN3:PKLR:RUSC1:ASH1L:MSTO1:YY1AP1:DAP3:GON4L:RXFP4:ARHGEF2:LMNA:RDH14:NT5C1B-RDH14:NT5C1B:CALCRL:TFPI:RPL37A | |||||||||||||||||||
9 | GWAScatalog | Cortical surface area (min-P) | 172 | 42 | 3.62E-47 | 2.29E-44 | FOXE3:FOXD2:INTS3:SLC27A3:GATAD2B:DENND4B:CRTC2:SLC39A1:CREB3L4:JTB:RAB13:RPS27:NUP210L:TPM3:C1orf43:UBAP2L:KCNN3:DCST2:DCST1:EFNA4:EFNA3:EFNA1:SLC50A1:DPM3:KRTCAP2:TRIM46:MUC1:THBS3:MTX1:HCN3:PKLR:RUSC1:ASH1L:MSTO1:YY1AP1:DAP3:GON4L:RXFP4:ARHGEF2:LMNA:RDH14:NT5C1B-RDH14:NT5C1B | |||||||||||||||||||
10 | GWAScatalog | Brain morphology (min-P) | 345 | 50 | 2.92E-44 | 1.61E-41 | FOXE3:FOXD2:INTS3:SLC27A3:GATAD2B:DENND4B:CRTC2:SLC39A1:CREB3L4:JTB:RAB13:RPS27:NUP210L:TPM3:C1orf43:UBAP2L:KCNN3:DCST2:DCST1:EFNA4:EFNA3:EFNA1:SLC50A1:DPM3:KRTCAP2:TRIM46:MUC1:THBS3:MTX1:HCN3:PKLR:RUSC1:ASH1L:MSTO1:YY1AP1:DAP3:GON4L:RXFP4:ARHGEF2:LMNA:RDH14:NT5C1B-RDH14:NT5C1B:CALCRL:TFPI:RPL37A:MAGI1:FOXP1:EPHA3:BANK1:SLC39A8 | |||||||||||||||||||
11 | GWAScatalog | Subcortical volume (min-P) | 308 | 48 | 5.34E-44 | 2.62E-41 | FOXE3:FOXD2:INTS3:SLC27A3:GATAD2B:DENND4B:CRTC2:SLC39A1:CREB3L4:JTB:RAB13:RPS27:NUP210L:TPM3:C1orf43:UBAP2L:KCNN3:DCST2:DCST1:EFNA4:EFNA3:EFNA1:SLC50A1:DPM3:KRTCAP2:TRIM46:MUC1:THBS3:MTX1:HCN3:PKLR:RUSC1:ASH1L:MSTO1:YY1AP1:DAP3:GON4L:RXFP4:ARHGEF2:LMNA:RDH14:NT5C1B-RDH14:NT5C1B:CALCRL:TFPI:RPL37A:MAGI1:FOXP1:EPHA3 | |||||||||||||||||||
12 | GWAScatalog | Body fat distribution (leg fat ratio) | 167 | 30 | 2.25E-29 | 9.95E-27 | DCST2:DCST1:EFNA4:EFNA3:EFNA1:DPM3:KRTCAP2:TRIM46:MUC1:THBS3:MTX1:HCN3:PKLR:RUSC1:ASH1L:MSTO1:YY1AP1:DAP3:GON4L:RXFP4:ARHGEF2:HHIP:AMZ1:GNA12:CCDC91:WWP2:MMP24:EIF6:FAM83C:GDF5 | |||||||||||||||||||
13 | GWAScatalog | Body fat distribution (trunk fat ratio) | 179 | 29 | 4.71E-27 | 1.89E-24 | DCST2:DCST1:EFNA4:EFNA3:EFNA1:DPM3:KRTCAP2:TRIM46:MUC1:THBS3:MTX1:HCN3:PKLR:RUSC1:ASH1L:MSTO1:YY1AP1:DAP3:GON4L:RXFP4:ARHGEF2:HHIP:AMZ1:GNA12:CCDC91:MMP24:EIF6:FAM83C:GDF5 | |||||||||||||||||||
14 | GWAScatalog | Asthma and major depressive disorder | 34 | 17 | 7.86E-26 | 2.90E-23 | ZKSCAN3:ZSCAN12:ZSCAN23:GPX6:TRIM27:ZNF311:OR2W1:OR2B3:OR2J3:OR2J2:OR14J1:OR5V1:OR12D3:OR12D2:OR11A1:OR10C1:OR2H1 | |||||||||||||||||||
15 | GWAScatalog | Cooked vegetable consumption | 24 | 14 | 9.33E-23 | 3.18E-20 | INTS3:SLC27A3:GATAD2B:DENND4B:CRTC2:SLC39A1:CREB3L4:JTB:RAB13:RPS27:NUP210L:TPM3:MFHAS1:MSRA | |||||||||||||||||||
16 | GWAScatalog | Autism spectrum disorder or schizophrenia | 355 | 29 | 1.60E-18 | 5.04E-16 | FOXP1:BANK1:SLC39A8:ZKSCAN3:ZSCAN12:ZSCAN23:GPX6:TRIM27:ZNF311:OR2W1:OR2B3:OR2J3:OR2J2:OR14J1:OR5V1:OR12D3:OR12D2:OR11A1:OR10C1:OR2H1:MAS1L:UBD:GABBR1:OR2H2:TMEM180:ACTR1A:SUFU:TRIM8:ARL3 | |||||||||||||||||||
17 | GWAScatalog | Hip circumference adjusted for BMI | 776 | 40 | 4.02E-18 | 1.18E-15 | DCST2:CALCRL:TFPI:FOXP1:MECOM:SPATA5:HHIP:ANAPC10:ABCE1:OTUD4:ZKSCAN3:GPX6:SCAND3:OR2J3:OR2J2:OR5V1:OR11A1:GABBR1:SUPT3H:CENPW:EPB41L2:EYA4:AMZ1:GNA12:MFHAS1:PAPPA:ACTR1A:TRIM8:ARL3:ADAMTS8:CCDC91:DEF8:DBNDD1:MAPT:WNT3:EDEM2:MMP24:FAM83C:UQCC1:GDF5 | |||||||||||||||||||
18 | GWAScatalog | Height | 1013 | 43 | 2.23E-16 | 6.18E-14 | SLC27A3:GATAD2B:KCNN3:DCST1:RDH14:FOXP1:MECOM:HHIP:ANAPC10:OTUD4:PDLIM4:SLC22A5:ZNF311:OR2J3:OR5V1:UBD:GABBR1:SUPT3H:RUNX2:CENPW:EPB41L2:AMZ1:GNA12:ELMO1:ENPP2:LPAR1:PAPPA:LOXL4:SUFU:CCDC91:MSRB3:WWP2:CDK10:ANKRD13B:SLC6A4:ARL17B:LRRC37A:LRRC37A2:ARL17A:KCNJ16:MMP24:EIF6:FAM83C:UQCC1:GDF5 | |||||||||||||||||||
19 | GWAScatalog | Crohn's disease | 505 | 31 | 3.24E-16 | 8.43E-14 | EFNA3:EFNA1:SLC50A1:DPM3:KRTCAP2:TRIM46:MUC1:THBS3:MTX1:HCN3:PKLR:RUSC1:ASH1L:MSTO1:YY1AP1:DAP3:GON4L:RXFP4:ARHGEF2:FOXP1:BANK1:SLC39A8:ACSL6:IL3:CSF2:PDLIM4:SLC22A4:SLC22A5:UBD:GABBR1:FAM53B | |||||||||||||||||||
20 | GWAScatalog | Inflammatory bowel disease | 538 | 31 | 1.86E-15 | 4.58E-13 | EFNA3:EFNA1:SLC50A1:DPM3:KRTCAP2:TRIM46:MUC1:THBS3:MTX1:HCN3:PKLR:RUSC1:ASH1L:MSTO1:YY1AP1:DAP3:GON4L:RXFP4:ARHGEF2:FOXP1:BANK1:SLC39A8:ACSL6:IL3:CSF2:PDLIM4:SLC22A4:SLC22A5:AMZ1:GNA12:FAM53B | |||||||||||||||||||
21 | GWAScatalog | Raw vegetable consumption | 16 | 9 | 8.01E-15 | 1.87E-12 | SLC27A3:GATAD2B:DENND4B:CRTC2:SLC39A1:MSRA:SKIDA1:MLLT10:DNAJC1 | |||||||||||||||||||
22 | GWAScatalog | Sarcoidosis (Lofgren's syndrome vs non-Lofgren's syndrome) | 9 | 7 | 2.92E-13 | 6.47E-11 | ZKSCAN3:ZSCAN12:TRIM27:OR2J3:OR12D3:OR12D2:MAS1L | |||||||||||||||||||
23 | GWAScatalog | Waist circumference adjusted for body mass index | 624 | 30 | 6.29E-13 | 1.33E-10 | KCNN3:DCST2:RXFP4:TFPI:SLC39A8:SPATA5:HHIP:ANAPC10:SLC22A4:GPX6:OR5V1:SUPT3H:AMZ1:GNA12:CPED1:CLDN23:MFHAS1:MSRA:SUFU:TRIM8:ARL3:FAM53B:CCDC91:CDK10:ZNF276:DBNDD1:MAPT:WNT3:EDEM2:GDF5 | |||||||||||||||||||
24 | GWAScatalog | Red vs. brown/black hair color | 16 | 8 | 9.45E-13 | 1.90E-10 | CHMP1A:CDK10:FANCA:SPIRE2:TCF25:MC1R:TUBB3:TUBB3:DEF8 | |||||||||||||||||||
25 | GWAScatalog | Estimated glomerular filtration rate | 458 | 25 | 4.16E-12 | 8.01E-10 | FOXD2:TRIM46:MUC1:MTX1:KIAA1614:RDH14:NT5C1B-RDH14:NT5C1B:CALCRL:MECOM:SLC22A4:OR2H1:SUPT3H:EYA4:PRKAG2:MCPH1:MFHAS1:MSRA:SUFU:FAM53B:METTL10:BMP4:WWP2:CHMP1A:SPATA2L:EDEM2 | |||||||||||||||||||
26 | GWAScatalog | Fruit consumption | 112 | 14 | 5.37E-12 | 9.91E-10 | SLC27A3:GATAD2B:DENND4B:CRTC2:SLC39A1:CREB3L4:JTB:RAB13:RPS27:NUP210L:MSRA:SKIDA1:MLLT10:DNAJC1 | |||||||||||||||||||
27 | GWAScatalog | Waist-to-hip ratio adjusted for BMI | 695 | 29 | 4.97E-11 | 8.79E-09 | KCNN3:DCST2:ASH1L:CALCRL:TFPI:SLC39A8:SPATA5:HHIP:ANAPC10:ABCE1:OR5V1:CENPW:EYA4:ELMO1:MFHAS1:MSRA:ACTR1A:SUFU:TRIM8:ARL3:ADAMTS8:MAPT:WNT3:KCNJ16:EDEM2:MMP24:EIF6:FAM83C:GDF5 | |||||||||||||||||||
28 | GWAScatalog | Bone mineral density (paediatric | 16 | 7 | 8.76E-11 | 1.49E-08 | CENPW:EYA4:CPED1:WNT16:FAM3C:TNFRSF11B:COLEC10 | |||||||||||||||||||
29 | GWAScatalog | Social communication problems | 26 | 8 | 1.05E-10 | 1.73E-08 | TRIM27:ZNF311:OR2W1:OR2B3:OR2J3:OR2J2:OR5V1:OR12D3 | |||||||||||||||||||
30 | GWAScatalog | Waist-hip index | 494 | 24 | 1.29E-10 | 2.04E-08 | KCNN3:DCST2:ASH1L:CALCRL:TFPI:SLC39A8:SPATA5:HHIP:ANAPC10:OR5V1:CENPW:EYA4:ELMO1:CPED1:CLDN23:MFHAS1:MSRA:ADAMTS8:MAPT:WNT3:EDEM2:MMP24:FAM83C:GDF5 | |||||||||||||||||||
31 | GWAScatalog | A body shape index | 341 | 19 | 1.32E-09 | 2.01E-07 | KCNN3:DCST2:RXFP4:CALCRL:TFPI:SLC39A8:SPATA5:HHIP:ANAPC10:OR5V1:CENPW:CLDN23:MFHAS1:MSRA:SUFU:MAPT:EDEM2:MMP24:GDF5 | |||||||||||||||||||
32 | GWAScatalog | Lung function (FVC) | 142 | 13 | 1.62E-09 | 2.39E-07 | RDH14:FOXP1:EPHA3:MECOM:OTUD4:ZKSCAN3:RUNX2:CENPW:CCDC91:MSRB3:WWP2:WNT3:UQCC1 | |||||||||||||||||||
33 | GWAScatalog | Left–right brain asymmetry | 23 | 7 | 1.77E-09 | 2.53E-07 | BBS9:DAAM1:SPIRE2:TUBB3:TUBB3:MAPT:ARL17B:LRRC37A:LRRC37A2:ARL17A | |||||||||||||||||||
34 | GWAScatalog | Handedness (Left-handed vs. non-left-handed) | 7 | 5 | 1.85E-09 | 2.56E-07 | MAPT:STH:ARL17B:LRRC37A:LRRC37A2:ARL17A:WNT3 | |||||||||||||||||||
35 | GWAScatalog | Appendicular lean mass | 600 | 24 | 6.19E-09 | 8.30E-07 | DCST2:LMNA:KIAA1614:MECOM:HHIP:ANAPC10:PDLIM4:OR2H2:SUPT3H:EPB41L2:EYA4:AMZ1:GNA12:ENPP2:PAPPA:RNF169:CCDC91:MSRB3:PYGO1:WWP2:SSH2:MAPT:MMP24:GDF5 | |||||||||||||||||||
36 | GWAScatalog | Hemoglobin levels | 304 | 17 | 9.65E-09 | 1.26E-06 | MTX1:PKLR:SLC39A8:TRIM27:OR2J2:OR12D3:UBD:PRKAG2:CHMP1A:SPATA33:CDK10:SPATA2L:FANCA:MC1R:EFCAB5:MAPT:LRRC37A:LRRC37A2 | |||||||||||||||||||
37 | GWAScatalog | Low tan response | 21 | 6 | 4.14E-08 | 5.23E-06 | CHMP1A:FANCA:SPIRE2:MC1R:DEF8:DBNDD1 | |||||||||||||||||||
38 | GWAScatalog | Lentiform nucleus volume | 5 | 4 | 4.59E-08 | 5.65E-06 | GATAD2B:DENND4B:SLC39A1:EPB41L2 | |||||||||||||||||||
39 | GWAScatalog | Urinary albumin-to-creatinine ratio | 99 | 10 | 5.10E-08 | 6.10E-06 | FOXD2:DPM3:KRTCAP2:TRIM46:MUC1:THBS3:MSTO1:SLC22A4:MLLT10:DNAJC1 | |||||||||||||||||||
40 | GWAScatalog | Birth weight | 230 | 14 | 7.21E-08 | 8.40E-06 | KCNN3:DCST2:LMNA:HHIP:CENPW:AMZ1:GNA12:MCPH1:ENPP2:LPAR1:PAPPA:MSRB3:KCNJ16:EDEM2 | |||||||||||||||||||
41 | GWAScatalog | Lung function in never smokers (low FEV1 vs high FEV1) | 13 | 5 | 1.08E-07 | 1.20E-05 | HHIP:ZKSCAN3:BBS9:CCDC91:WWP2 | |||||||||||||||||||
42 | GWAScatalog | Empathy quotient | 13 | 5 | 1.08E-07 | 1.20E-05 | GATAD2B:DENND4B:CRTC2:SLC39A1:CREB3L4 | |||||||||||||||||||
43 | GWAScatalog | Prostate cancer | 273 | 14 | 5.86E-07 | 6.33E-05 | DENND4B:KCNN3:DCST2:DCST1:EFNA4:EFNA3:EFNA1:SLC50A1:DPM3:MECOM:ACTR1A:SUFU:TRIM8:ARL3 | |||||||||||||||||||
44 | GWAScatalog | Bone mineral density (paediatric | 8 | 4 | 6.28E-07 | 6.62E-05 | CENPW:CPED1:WNT16:FAM3C | |||||||||||||||||||
45 | GWAScatalog | Heel bone mineral density | 671 | 22 | 8.56E-07 | 8.81E-05 | THBS3:KIAA1614:CALCRL:HHIP:OTUD4:TRIM27:SUPT3H:EPB41L2:EYA4:AMZ1:SHFM1:CPED1:WNT16:FAM3C:MCPH1:TNFRSF11B:COLEC10:PAPPA:CCDC91:MSRB3:BMP4:CORO6 | |||||||||||||||||||
46 | GWAScatalog | Forearm bone mineral density | 3 | 3 | 9.52E-07 | 9.57E-05 | CPED1:WNT16:FAM3C | |||||||||||||||||||
47 | GWAScatalog | Asthma | 698 | 22 | 1.64E-06 | 0.0001612993536 | MAGI1:FOXP1:MECOM:PDLIM4:SLC22A4:SLC22A5:TRIM27:ZNF311:OR2W1:OR2B3:OR2J3:OR2J2:OR14J1:OR5V1:OR12D3:OR12D2:OR11A1:OR10C1:OR2H1:BBS9:TNFRSF11B:COLEC10 | |||||||||||||||||||
48 | GWAScatalog | Intraocular pressure | 309 | 14 | 2.54E-06 | 0.0002441011232 | FOXP1:MECOM:SUPT3H:RUNX2:CENPW:BBS9:PRKAG2:MCPH1:ANGPT2:ANGPT1:ADAMTS8:PRTG:FANCA:WNT3 | |||||||||||||||||||
49 | GWAScatalog | Lung function (FEV1/FVC) | 152 | 10 | 2.79E-06 | 0.0002631206908 | KRTCAP2:NT5C1B-RDH14:NT5C1B:MECOM:HHIP:OTUD4:ZKSCAN3:RUNX2:BMP4:SSH2:EFCAB5 | |||||||||||||||||||
50 | GWAScatalog | Lung function (FEV1) | 64 | 7 | 3.19E-06 | 0.0002938157725 | NT5C1B-RDH14:NT5C1B:HHIP:OTUD4:ZKSCAN3:CCDC91:MSRB3:WNT3 | |||||||||||||||||||
51 | GWAScatalog | Medial thalamic nuclei volume | 4 | 3 | 3.78E-06 | 0.0003215957517 | AMZ1:GNA12:NUAK1 | |||||||||||||||||||
52 | GWAScatalog | Pediatric bone mineral content (radius) | 4 | 3 | 3.78E-06 | 0.0003215957517 | CPED1:WNT16:FAM3C | |||||||||||||||||||
53 | GWAScatalog | Handedness (Right-handed vs. non-right-handed) | 4 | 3 | 3.78E-06 | 0.0003215957517 | STH:ARL17B:LRRC37A:LRRC37A2:ARL17A | |||||||||||||||||||
54 | GWAScatalog | Serum cancer antigen 15.3 levels | 4 | 3 | 3.78E-06 | 0.0003215957517 | THBS3:MTX1:MSTO1 | |||||||||||||||||||
55 | GWAScatalog | Lung cancer in ever smokers | 93 | 8 | 3.91E-06 | 0.0003263487564 | LMNA:ZSCAN23:TRIM27:ZNF311:OR2J3:OR2J2:OR14J1:GABBR1 | |||||||||||||||||||
56 | GWAScatalog | Cortical thickness | 12 | 4 | 4.31E-06 | 0.0003530126185 | WNT16:LPAR1:DAAM1:WNT3 | |||||||||||||||||||
57 | GWAScatalog | Peak expiratory flow | 96 | 8 | 4.96E-06 | 0.0003992755321 | KRTCAP2:RDH14:OTUD4:CCDC91:MSRB3:BMP4:SSH2:UQCC1 | |||||||||||||||||||
58 | GWAScatalog | Squamous cell carcinoma | 27 | 5 | 6.06E-06 | 0.0004790224979 | FOXP1:SPATA33:MC1R:TUBB3:TUBB3:DEF8 | |||||||||||||||||||
59 | GWAScatalog | Subcortical brain region volumes | 14 | 4 | 8.58E-06 | 0.000654411309 | CENPW:MSRB3:MAPT:STH | |||||||||||||||||||
60 | GWAScatalog | Bone mineral density (paediatric | 14 | 4 | 8.58E-06 | 0.000654411309 | CENPW:CPED1:WNT16:FAM3C | |||||||||||||||||||
61 | GWAScatalog | Gastric adenocarcinoma (histologically verified) | 5 | 3 | 9.38E-06 | 0.0007034320341 | MUC1:MTX1:HCN3 | |||||||||||||||||||
62 | GWAScatalog | Squamous cell lung carcinoma | 77 | 7 | 1.11E-05 | 0.0008167086009 | KCNN3:ZSCAN12:GPX6:ZNF311:OR2J3:OR2J2:OR14J1 | |||||||||||||||||||
63 | GWAScatalog | White matter integrity (fractional anisotropy) | 15 | 4 | 1.16E-05 | 0.0008419415472 | RPL37A:OR2J2:SPIRE2:TCF25 | |||||||||||||||||||
64 | GWAScatalog | Occipital lobe volume | 6 | 3 | 1.86E-05 | 0.00132902879 | THBS3:CENPW:DAAM1 | |||||||||||||||||||
65 | GWAScatalog | Urate levels | 234 | 11 | 2.21E-05 | 0.001553037627 | DPM3:TRIM46:MTX1:PKLR:GON4L:LMNA:MECOM:OR12D2:PRKAG2:CLDN23:METTL10 | |||||||||||||||||||
66 | GWAScatalog | Optic disc size | 89 | 7 | 2.87E-05 | 0.001985749627 | EFNA3:FOXP1:KIF6:CENPW:SUFU:BMP4:DAAM1 | |||||||||||||||||||
67 | GWAScatalog | Lateral ventricular volume in normal aging | 7 | 3 | 3.23E-05 | 0.00213654816 | MLLT10:NUAK1:C16orf95 | |||||||||||||||||||
68 | GWAScatalog | Ulna and radius bone mineral density | 7 | 3 | 3.23E-05 | 0.00213654816 | GABBR1:WNT16:FAM3C | |||||||||||||||||||
69 | GWAScatalog | Intracranial volume | 7 | 3 | 3.23E-05 | 0.00213654816 | CENPW:MAPT:STH | |||||||||||||||||||
70 | GWAScatalog | Offspring birth weight | 125 | 8 | 3.45E-05 | 0.002245847132 | KCNN3:DCST2:HHIP:AMZ1:GNA12:ENPP2:LPAR1:EDEM2 | |||||||||||||||||||
71 | GWAScatalog | Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test) | 299 | 12 | 4.44E-05 | 0.002848817301 | ANAPC10:ABCE1:ACTR1A:SUFU:TRIM8:ARL3:KCNJ16:EDEM2:MMP24:EIF6:FAM83C:GDF5 | |||||||||||||||||||
72 | GWAScatalog | Periventricular white matter hyperintensities | 41 | 5 | 5.03E-05 | 0.003157910188 | GON4L:CALCRL:PLEKHG1:ANGPT1:C16orf95 | |||||||||||||||||||
73 | GWAScatalog | Skin pigmentation traits | 8 | 3 | 5.14E-05 | 0.003157910188 | SPATA33:FANCA:MC1R | |||||||||||||||||||
74 | GWAScatalog | Bone mineral density (paediatric | 8 | 3 | 5.14E-05 | 0.003157910188 | CPED1:WNT16:FAM3C | |||||||||||||||||||
75 | GWAScatalog | Chronic obstructive pulmonary disease | 137 | 8 | 6.63E-05 | 0.004020285724 | MECOM:HHIP:ZSCAN12:OR12D3:AMZ1:MFHAS1:CCDC91:EFCAB5 | |||||||||||||||||||
76 | GWAScatalog | Waist-to-hip ratio adjusted for BMI (age >50) | 178 | 9 | 7.15E-05 | 0.00426320729 | ACTR1A:SUFU:TRIM8:ARL3:EDEM2:MMP24:EIF6:FAM83C:GDF5 | |||||||||||||||||||
77 | GWAScatalog | Male-pattern baldness | 221 | 10 | 7.23E-05 | 0.00426320729 | FOXD2:SUPT3H:CENPW:ANGPT1:FAM53B:MAPT:STH:ARL17B:LRRC37A:LRRC37A2:ARL17A:WNT3 | |||||||||||||||||||
78 | GWAScatalog | Daytime sleep phenotypes | 144 | 8 | 9.42E-05 | 0.005481894342 | HHIP:TRIM27:ZNF311:OR2B3:OR2J3:OR2J2:AMZ1:GNA12 | |||||||||||||||||||
79 | GWAScatalog | Handedness (non-right-handed vs right-handed) | 2 | 2 | 9.73E-05 | 0.005518887991 | MAPT:WNT3 | |||||||||||||||||||
80 | GWAScatalog | Femoral neck size | 2 | 2 | 9.73E-05 | 0.005518887991 | HHIP:GDF5 | |||||||||||||||||||
81 | GWAScatalog | FEV1 | 148 | 8 | 0.0001139868315 | 0.006384705435 | RDH14:FOXP1:MECOM:OTUD4:CCDC91:MSRB3:WWP2:UQCC1 | |||||||||||||||||||
82 | GWAScatalog | Alcohol use disorder (total score) | 26 | 4 | 0.0001167481807 | 0.006444869629 | SLC39A8:MAPT:STH:WNT3 | |||||||||||||||||||
83 | GWAScatalog | Medication use (agents acting on the renin-angiotensin system) | 111 | 7 | 0.0001179738847 | 0.006444869629 | MECOM:SLC39A8:PLEKHG1:PRKAG2:MFHAS1:MSRA:CHMP1A | |||||||||||||||||||
84 | GWAScatalog | QRS complex (12-leadsum) | 11 | 3 | 0.0001481146291 | 0.007992771143 | EFCAB5:NSRP1:MAPT | |||||||||||||||||||
85 | GWAScatalog | Takayasu arteritis | 53 | 5 | 0.0001750312126 | 0.009331483323 | GPX6:OR2B3:OR2J3:OR2J2:OR14J1 | |||||||||||||||||||
86 | GWAScatalog | Body size at age 10 | 250 | 10 | 0.000198682289 | 0.01046629915 | ARHGEF2:CALCRL:MAGI1:BANK1:HHIP:TRIM27:BBS9:CLDN23:MSRA:LRRC37A:LRRC37A2 | |||||||||||||||||||
87 | GWAScatalog | Hand grip strength | 122 | 7 | 0.0002124325471 | 0.01105898848 | FOXP1:BANK1:SLC39A8:TRIM27:FAM3C:MLLT10:WWP2 | |||||||||||||||||||
88 | GWAScatalog | Refractive error | 1381 | 28 | 0.0002201672469 | 0.01132837288 | EFNA3:EFNA1:SLC50A1:KRTCAP2:MAGI1:FOXP1:BANK1:SLC39A8:HHIP:OTUD4:ZKSCAN3:ZSCAN12:ZSCAN23:GPX6:MAS1L:UBD:CLDN23:MFHAS1:MSRA:ANGPT1:ACTR1A:SUFU:TRIM8:ARL3:MAPT:STH:WNT3:GDF5 | |||||||||||||||||||
89 | GWAScatalog | Cutaneous squamous cell carcinoma | 31 | 4 | 0.000236416432 | 0.01188798536 | FOXP1:TCF25:MC1R:TUBB3:TUBB3 | |||||||||||||||||||
90 | GWAScatalog | Cortical volume | 31 | 4 | 0.000236416432 | 0.01188798536 | FOXD2:ENPP2:MSRB3:DAAM1 | |||||||||||||||||||
91 | GWAScatalog | Brown vs. black hair color | 32 | 4 | 0.0002681148137 | 0.01332118379 | CDK10:TCF25:MC1R:DEF8 | |||||||||||||||||||
92 | GWAScatalog | Serum alkaline phosphatase levels | 310 | 11 | 0.0002709393313 | 0.01332118379 | KIAA1614:UBD:OR2H2:SUPT3H:SHFM1:TNFRSF11B:COLEC10:TRIM8:AQP9:MAPT:EDEM2 | |||||||||||||||||||
93 | GWAScatalog | Lateral thalamic nuclei volume | 3 | 2 | 0.0002899427871 | 0.01394561775 | GMNC:SLC39A8 | |||||||||||||||||||
94 | GWAScatalog | Ischemic heart disease in rheumatoid arthritis | 3 | 2 | 0.0002899427871 | 0.01394561775 | LMNA:WNT16 | |||||||||||||||||||
95 | GWAScatalog | Reaction time | 33 | 4 | 0.0003027533541 | 0.0142519531 | MAPT:ARL17B:LRRC37A:LRRC37A2:ARL17A:WNT3 | |||||||||||||||||||
96 | GWAScatalog | Alzheimer's disease in APOE e4- carriers | 33 | 4 | 0.0003027533541 | 0.0142519531 | KCNN3:ACSL6:MAPT:WNT3 | |||||||||||||||||||
97 | GWAScatalog | Gastric cancer | 14 | 3 | 0.0003196770559 | 0.01473511429 | MUC1:MTX1:HCN3 | |||||||||||||||||||
98 | GWAScatalog | Neonatal white matter microstructure | 14 | 3 | 0.0003196770559 | 0.01473511429 | SLC27A3:MECOM:UQCC1 | |||||||||||||||||||
99 | GWAScatalog | White matter hyperintensity volume x hypertension interaction (2df) | 34 | 4 | 0.0003404864598 | 0.01553250087 | CALCRL:PLEKHG1:LPAR1:C16orf95 | |||||||||||||||||||
100 | GWAScatalog | Monocyte count | 375 | 12 | 0.0003681438077 | 0.01662281989 | LMNA:KIAA1614:MECOM:ANAPC10:SLC22A4:SLC22A5:RUNX2:AMZ1:GNA12:LPAR1:FANCA:SSH2 | |||||||||||||||||||